AbbVie to buy ImmunoGen for $10.1 billion
Nov 30 (Reuters) - AbbVie ABBV.N said on Thursday it will buy cancer drugmaker ImmunoGen IMGN.O for $10.1 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli) ((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manaswrites15;))
Recent news on ImmunoGen
See all newsBrief: Abbvie Completes Acquisition Of Immunogen
Brief: Abbvie Qtrly Adj EPS $2.79 Vs LSEG IBES Estimate $2.77
Brief: Immunogen Says German Federal Cartel Office Approved Merger With Abbvie Unconditionally
Ambrx Biopharma surges on J&J's buyout announcement
Street View: BioMarin-Elliott settlement likely eases investor frustration